Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen awaiting FDA decision on cancer drug Kyprolis
Amgen awaiting FDA decision on cancer drug Kyprolis
Amgen awaiting FDA decision on cancer drug Kyprolis
Submitted by
admin
on July 14, 2015 - 11:44am
Source:
BioPharma Dive
News Tags:
Amgen
FDA
Kyprolis
Multiple Myeloma
Headline:
Amgen awaiting FDA decision on cancer drug Kyprolis
Do Not Allow Advertisers to Use My Personal information
